Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: SUNDANCE STRATEGIES, INC.
CIK: 1171838
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2011-06-28
Last Filing Date: 2025-02-14
SEC Filings
Start End Frame Filed ACCN Value View
2018-10-01 2018-12-31 CY2017Q4 2019-11-25 0001493152-19-018382 $ 42,943,495 View
2018-04-01 2019-03-31 CY2017 2020-01-16 0001493152-20-000649 $ 42,455,217 View
2019-04-01 2019-06-30 CY2018Q2 2020-02-19 0001493152-20-002704 $ 37,828,441 View
2019-07-01 2019-09-30 CY2018Q3 2020-02-19 0001493152-20-002706 $ 37,828,441 View
2019-10-01 2019-12-31 CY2018Q4 2020-02-19 0001493152-20-002708 $ 37,828,441 View
2018-12-05 2022-12-31 CY2022Q4I 2023-02-14 0001493152-23-004805 $ 589,858 View
2018-12-05 2018-12-06 CY2018Q4I 2023-08-14 0001493152-23-028534 $ 8,000,000 View
2024-04-01 2024-06-30 CY2024Q2 2024-08-13 0001493152-24-031412 $ 1,000,000 View
2014-04-01 2014-06-30 CY2014Q2 2014-08-14 0001010412-14-000139 $ 43,015,941 View
2024-04-01 2024-09-30 CY2024Q2I 2024-11-08 0001493152-24-044334 $ 1,000,000 View
2024-04-01 2024-12-31 CY2024Q4 2025-02-14 0001493152-25-006815 $ 1,450,000 View
2019-04-01 2020-03-31 CY2018 2020-08-11 0001493152-20-015137 $ 37,828,441 View
2017-04-01 2017-06-30 CY2017Q2 2019-04-08 0000891092-19-004397 $ 44,128,441 View
2022-04-01 2023-03-31 CY2021 2023-06-29 0001493152-23-022963 $ 463,012 View
2023-04-01 2024-03-31 CY2024Q1I 2024-07-01 0001493152-24-025765 $ 79,779 View
2016-04-01 2016-06-30 CY2015Q2 2016-08-09 0001580957-16-000785 $ 44,140,669 View
2016-07-01 2016-09-30 CY2015Q3 2016-11-09 0001580957-16-000932 $ 44,128,441 View
2013-07-01 2013-09-30 CY2013Q4 2013-11-14 0001010412-13-000280 $ 42,261,441 View
2013-10-01 2013-12-31 CY2013 2014-02-14 0001010412-14-000019 $ 42,261,441 View
2014-07-01 2014-09-30 CY2014Q3 2014-11-14 0001010412-14-000185 $ 43,163,575 View
2013-04-01 2014-03-31 CY2013Q1 2014-07-21 0001010412-14-000126 $ 42,559,660 View
2015-04-01 2015-06-30 CY2014Q2 2015-08-10 0001010412-15-000125 $ 43,433,750 View
2015-07-01 2015-09-30 CY2014Q3 2015-11-10 0001548123-15-000377 $ 44,315,941 View
2001-12-14 2011-06-30 CY2011Q2I 2011-08-15 0001023175-11-000482 $ -9,639 View
2001-12-14 2011-09-30 CY2011Q3I 2011-11-14 0001078782-11-003251 $ -11,536 View
2001-12-14 2011-12-31 CY2011Q4I 2012-02-09 0001078782-12-000337 $ -13,753 View
2004-09-01 2004-09-30 CY2012Q3I 2012-11-13 0001078782-12-002793 $ 1,200,000 View
2012-10-01 2012-12-31 CY2012Q4 2013-02-14 0001078782-13-000317 $ 3,760,000 View
2016-10-01 2016-12-31 CY2015Q4 2017-04-17 0001580957-17-000296 $ 44,128,441 View
2004-09-01 2004-09-30 CY2012Q2I 2012-08-10 0001078782-12-001966 $ 1,200,000 View
2020-04-01 2021-03-31 CY2020 2021-06-29 0001493152-21-015565 $ 38,904,715 View
2004-04-01 2005-03-31 CY2010Q1I 2011-06-28 0001023175-11-000355 $ 27,433 View
2004-04-01 2005-03-31 CY2004 2012-07-16 0001078782-12-001796 $ 27,433 View
2014-04-01 2015-03-31 CY2014 2015-06-15 0001010412-15-000084 $ 43,137,990 View
2020-10-01 2020-12-31 CY2019Q4 2021-02-16 0001493152-21-003741 $ 39,868,006 View
2015-04-01 2016-03-31 CY2014 2016-06-14 0001580957-16-000709 $ 44,026,832 View
2016-04-01 2017-03-31 CY2015 2018-04-12 0001580957-18-000172 $ 44,131,515 View
2021-04-01 2021-12-31 CY2021Q4I 2022-02-14 0001493152-22-004540 $ 285,192 View
2021-04-01 2022-03-31 CY2022Q1I 2022-06-29 0001493152-22-018095 $ 0 View
2023-04-01 2023-12-31 CY2022Q4 2024-02-14 0001493152-24-006487 $ 361,900 View
2013-01-31 2013-03-31 CY2013Q1 2013-07-16 0001010412-13-000195 $ 35,469,179 View
2013-04-01 2013-06-30 CY2013Q2I 2013-08-12 0001010412-13-000226 $ 41,280,078 View
2014-10-01 2014-12-31 CY2013Q4 2015-02-17 0001010412-15-000030 $ 43,185,941 View
2015-10-01 2015-12-31 CY2015Q4 2016-02-09 0000912282-16-000555 $ 44,315,941 View
2018-04-01 2018-06-30 CY2017Q2 2019-10-24 0001493152-19-015907 $ 44,128,441 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-16 0001493152-21-020217 $ 40,864,963 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-15 0001493152-21-028498 $ 41,308,441 View
2017-07-01 2017-09-30 CY2017Q3 2019-04-25 0001493152-19-005959 $ 44,128,441 View
2017-10-01 2017-12-31 CY2017Q4 2019-04-25 0001493152-19-005960 $ 44,128,441 View
2017-04-01 2018-03-31 CY2017 2019-10-16 0001493152-19-015587 $ 44,128,441 View
2022-06-19 2022-06-20 CY2021Q2 2022-08-15 0001493152-22-022941 $ 1 View
2021-07-01 2021-09-30 CY2021Q3 2022-11-14 0001493152-22-032102 $ 18,480 View
2023-04-01 2023-09-30 CY2022Q3 2023-11-14 0001493152-23-040910 $ 361,900 View
2018-07-01 2018-09-30 CY2017Q3 2019-11-15 0001493152-19-017692 $ 44,825,215 View
2020-04-01 2020-06-30 CY2019Q2 2020-08-19 0001493152-20-016284 $ 37,828,441 View
2020-07-01 2020-09-30 CY2019Q3 2020-11-16 0001493152-20-021719 $ 37,828,441 View
SEC Facts By Type
Type Name Description View
us-gaap Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Common Stock, Shares Subscribed but Unissued Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Deferred Tax Liabilities, Net, Current Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as current. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Increase (Decrease) in Accounts Payable, Related Parties The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. View
us-gaap Increase (Decrease) in Interest Payable, Net The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. View
us-gaap Interest Paid, Including Capitalized Interest, Operating and Investing Activities Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. View
us-gaap Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Five Face value of the life insurance policies underlying the life settlement contracts accounted for under the fair value method maturing in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, Year Four Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Long-term Line of Credit The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Payments of Stock Issuance Costs The cash outflow for cost incurred directly with the issuance of an equity security. View
us-gaap Payments to Acquire Businesses, Gross The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. View
us-gaap Payments to Acquire Investments The cash outflow associated with the purchase of all investments (debt, security, other) during the period. View
us-gaap Payment to Acquire Life Insurance Policy, Investing Activities Amount of cash outflow for payment of premium on corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy. View
us-gaap Payments to Acquire Machinery and Equipment The cash outflow for acquisition of machinery and equipment. View
us-gaap Payments to Acquire Notes Receivable The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Repayments of Related Party Debt The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. View
us-gaap Temporary Equity, Redemption Price Per Share Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Temporary Equity, Shares Issued The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Notes Payable, Related Parties, Noncurrent The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle). View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
dei Entity Listing, Par Value Per Share The par value per share of security quoted in same currency as Trading currency. Example: '0.01'. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Accounts Payable and Accrued Liabilities, Noncurrent Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Accrued Liabilities Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Additional Paid in Capital, Common Stock Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. View
us-gaap APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other. View
us-gaap Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. View
us-gaap Share-based Payment Arrangement, Expense Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. View
us-gaap Deferred Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Noncurrent Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. View
us-gaap Business Acquisition, Percentage of Voting Interests Acquired Percentage of voting equity interests acquired at the acquisition date in the business combination. View
us-gaap Cash Acquired from Acquisition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, FDIC Insured Amount The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise price per share or per unit of warrants or rights outstanding. View
us-gaap Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. View
us-gaap Class of Warrant or Right, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. View
us-gaap Class of Warrant or Right, Outstanding Number of warrants or rights outstanding. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Amount of subscription receivable from investors who have been allocated common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Subscriptions Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Convertible Debt, Current The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Convertible Debt, Noncurrent Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock. View
us-gaap Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period. View
us-gaap Customer Advances, Current The current portion of prepayments received from customers for goods or services to be provided in the future. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Debt Conversion, Original Debt, Amount "The amount of the original debt being converted in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Long-term Debt, Gross Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. View
us-gaap Debt Instrument, Convertible, Number of Equity Instruments The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity. View
us-gaap Debt Instrument, Face Amount Face (par) amount of debt instrument at time of issuance. View
us-gaap Debt Instrument, Interest Rate, Stated Percentage Contractual interest rate for funds borrowed, under the debt agreement. View
us-gaap Debt Instrument, Periodic Payment Amount of the required periodic payments including both interest and principal payments. View
us-gaap Deferred Federal Income Tax Expense (Benefit) Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Liabilities, Gross Amount of deferred tax liability attributable to taxable temporary differences. View
us-gaap Deferred Other Tax Expense (Benefit) Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods. View
us-gaap Deferred State and Local Income Tax Expense (Benefit) Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Deferred Tax Assets, Gross Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Net of Valuation Allowance Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Other Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. View
us-gaap Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Deferred Tax Liabilities, Investments Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments). View
us-gaap Deferred Tax Liabilities, Net, Noncurrent Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent. View
us-gaap Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. View
us-gaap Derivative Asset, Notional Amount Nominal or face amount used to calculate payments on the derivative asset. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Due to Related Parties Carrying amount as of the balance sheet date of obligations due all related parties. View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. View
us-gaap Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Amount of cost to be recognized for option under share-based payment arrangement. View
us-gaap Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) Amount per share or per unit assigned to the consideration received of equity securities issued for development stage entities. View
us-gaap Extinguishment of Debt, Amount Gross amount of debt extinguished. View
us-gaap Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. View
us-gaap Federal Income Tax Expense (Benefit), Continuing Operations Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations. View
us-gaap Financial Instruments, Owned, at Fair Value The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings. View
us-gaap Financial Instrument Subject to Mandatory Redemption, Maturity, Year One Amount of mandatorily redeemable capital stock maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Financing Interest Expense This element represents interest incurred for borrowed money which was used to produce goods or render services. View
us-gaap Gain (Loss) on Sale of Investments The net realized gain (loss) on investments sold during the period, not including gains (losses) on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity, which, for cash flow reporting, is a component of proceeds from investing activities. View
us-gaap Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. View
us-gaap Gain (Loss) on Extinguishment of Debt Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. View
us-gaap Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. View
us-gaap Debt Securities, Held-to-maturity Amount of investment in debt security measured at amortized cost (held-to-maturity). View
us-gaap Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity). View
us-gaap Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity). View
us-gaap Debt Securities, Held-to-maturity, Fair Value Fair value of investment in debt security measured at amortized cost (held-to-maturity). View
us-gaap Other than Temporary Impairment Losses, Investments The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. View
us-gaap Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. View
us-gaap Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. View
us-gaap Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. View
us-gaap Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit). View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. View
us-gaap Increase (Decrease) in Accrued Interest Receivable, Net The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. View
us-gaap Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. View
us-gaap Increase (Decrease) in Other Current Assets Amount of increase (decrease) in current assets classified as other. View
us-gaap Increase (Decrease) in Other Current Assets and Liabilities, Net Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other. View
us-gaap Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other. View
us-gaap Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method. View
us-gaap Interest Expense Amount of the cost of borrowed funds accounted for as interest expense. View
us-gaap Interest Income, Operating Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. View
us-gaap Interest Income, Other Amount of interest income earned from interest bearing assets classified as other. View
us-gaap Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. View
us-gaap Interest Payable, Current Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Interest Payable Amount of interest payable on debt, including, but not limited to, trade payables. View
us-gaap Interest Receivable Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. View
us-gaap Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. View
us-gaap Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. View
us-gaap Operating Leases, Rent Expense Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Liabilities Assumed The fair value of liabilities assumed in noncash investing or financing activities. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Liabilities, Noncurrent Amount of obligation due after one year or beyond the normal operating cycle, if longer. View
us-gaap Liability for Future Policy Benefit, before Reinsurance Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract. View
us-gaap Liability for Future Policy Benefits, Life Amount of accrued obligation to policyholders that relates to insured events under long-term life insurance contracts. View
us-gaap Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit. View
us-gaap Life Settlement Contracts, Fair Value Method, Face Value Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the fair value method. View
us-gaap Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Four Face value of the life insurance policies underlying the life settlement contracts accounted for under the fair value method maturing in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Three Face value of the life insurance policies underlying the life settlement contracts accounted for under the fair value method maturing in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Two Face value of the life insurance policies underlying the life settlement contracts accounted for under the fair value method maturing in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. View
us-gaap Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Five Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Four Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Three Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Two Face value of life insurance policy underlying life settlement contract accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contracts, Fair Value Method, Number of Contracts Number of life settlement contracts accounted for under the fair value method. View
us-gaap Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Five Number of life settlement contracts accounted for under fair value method maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Four Number of life settlement contracts accounted for under fair value method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Three Number of life settlement contracts accounted for under fair value method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Two Number of life settlement contracts accounted for under fair value method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contracts, Investment Method, Carrying Amount Carrying amount of life settlement contracts accounted for under the investment method. View
us-gaap Life Settlement Contracts, Investment Method, Face Value Face value (death benefits) of the life insurance policies underlying the life settlement contracts accounted for under the investment method. View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, after Year Five Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, Year One Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, Year Five Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, Year Three Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Face Value, Maturity, Year Two Face value of life insurance policy underlying life settlement contract accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contracts, Investment Method, Premiums to be Paid Amount of life insurance premiums anticipated to be paid to keep the life settlement contracts accounted for under the investment method in force. View
us-gaap Life Settlement Contracts, Investment Method, Number of Contracts Number of life settlement contracts accounted for under the investment method. View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, after Year Five Number of life settlement contracts accounted for under investment method maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year One Number of life settlement contracts accounted for under investment method maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Five Number of life settlement contracts accounted for under investment method maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Four Number of life settlement contracts accounted for under investment method maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Three Number of life settlement contracts accounted for under investment method maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Two Number of life settlement contracts accounted for under investment method maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, after Year Five Amount of life insurance premium accounted for under investment method to be paid after fifth fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, Year One Amount of life insurance premium accounted for under investment method to be paid in next fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, Year Five Amount of life insurance premium accounted for under investment method to be paid in fifth fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, Year Four Amount of life insurance premium accounted for under investment method to be paid in fourth fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, Year Three Amount of life insurance premium accounted for under investment method to be paid in third fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Life Settlement Contract, Investment Method, Premium to be Paid, Year Two Amount of life insurance premium accounted for under investment method to be paid in second fiscal year following current fiscal year to keep life settlement contract in force. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Financing Receivable, after Allowance for Credit Loss Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement. View
us-gaap Notes Reduction The value of notes retired (or transferred to another entity) in noncash investing or financing transactions. View
us-gaap Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) Amount borrowed under the credit facility as of the balance sheet date. View
us-gaap Line of Credit Facility, Maximum Borrowing Capacity Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. View
us-gaap Line of Credit Facility, Remaining Borrowing Capacity Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding). View
us-gaap Loan Processing Fee Expenses paid for obtaining loans which includes expenses such as application and origination fees. View
us-gaap Long-Term Debt, Maturity, Year One Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). View
us-gaap Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. View
us-gaap Loss Contingency, Damages Sought, Value The value (monetary amount) of the award the plaintiff seeks in the legal matter. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Financing Activities, Continuing Operations Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Investing Activities, Continuing Operations Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Cash Provided by (Used in) Operating Activities, Continuing Operations Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). View
us-gaap Financing Receivable, before Allowance for Credit Loss, Current Amount, before allowance for credit loss, of financing receivable, classified as current. View
us-gaap Notes Payable Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. View
us-gaap Notes Payable, Current Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Notes Payable, Related Parties The amount for notes payable (written promise to pay), due to related parties. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Operating Leases, Rent Expense, Net Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Other Accrued Liabilities, Current Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Assets, Current Amount of current assets classified as other. View
us-gaap Other Assets, Miscellaneous, Noncurrent Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer. View
us-gaap Other Assets, Noncurrent Amount of noncurrent assets classified as other. View
us-gaap Other Commitment Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. View
us-gaap Other Liabilities, Current Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. View
us-gaap Other Long-term Debt Amount of long-term debt classified as other. View
us-gaap Other Nonoperating Income Amount of income related to nonoperating activities, classified as other. View
us-gaap Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other. View
us-gaap Other Notes Payable Amount of long-term notes payable classified as other. View
us-gaap Other Restricted Assets, Noncurrent Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other. View
us-gaap Other Significant Noncash Transaction, Value of Consideration Given "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Payments for Advance to Affiliate The cash outflow from advancing money to an affiliate (an entity that is related but not strictly controlled by the entity). View
us-gaap Payments for (Proceeds from) Loans Receivable The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services. View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Payments of Loan Costs The cash outflow for loan origination associated cost which is usually collected through escrow. View
us-gaap Payments to Acquire Furniture and Fixtures The cash outflow for acquisition of furniture and fixtures. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Premiums Receivable, Net The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts. View
us-gaap Prepaid Expense and Other Assets Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. View
us-gaap Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap Proceeds from Collection of Loans Receivable The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services. View
us-gaap Proceeds from Collection of Long-term Loans to Related Parties The cash inflow associated with collection, whether partial or full, of long-term loans to a related party. Alternate caption: Proceeds from Advances to Affiliates. View
us-gaap Proceeds from Convertible Debt The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Proceeds from Issuance of Debt The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. View
us-gaap Proceeds from Issuance of Private Placement The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. View
us-gaap Proceeds from Issuance of Warrants The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). View
us-gaap Proceeds from Life Insurance Policy Amount of cash inflow for proceeds from settlement of corporate-owned life insurance policy, classified as investing activities. Includes, but is not limited to, bank-owned life insurance policy. View
us-gaap Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation. View
us-gaap Proceeds from Other Debt Amount of cash inflow from debt classified as other. View
us-gaap Proceeds from Other Equity Amount of cash inflow from the issuance of equity classified as other. View
us-gaap Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Proceeds from (Repayments of) Related Party Debt Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts. View
us-gaap Proceeds from Sale and Maturity of Other Investments The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy. View
us-gaap Proceeds from Sale of Machinery and Equipment The cash inflow from sale of machinery and equipment. View
us-gaap Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Receivable from Shareholders or Affiliates for Issuance of Capital Stock Amount due from owner or affiliate of reporting entity for issuance of shares. Includes, but is not limited to, amount due for award under share-based payment arrangement. Excludes amount due from officer or director. View
us-gaap Related Party Transaction, Amounts of Transaction Amount of transactions with related party during the financial reporting period. View
us-gaap Related Party Transaction, Rate Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties. View
us-gaap Repayments of Convertible Debt The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. View
us-gaap Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation. View
us-gaap Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) Number of shares issued as consideration for cash for development stage entities. View
us-gaap Restructuring and Related Cost, Incurred Cost Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Selling and Marketing Expense The aggregate total amount of expenses directly related to the marketing or selling of products or services. View
us-gaap Share-based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Number of equity instruments other than options outstanding, including both vested and non-vested instruments. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted average price of options that were either forfeited or expired. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Gross number of share options (or share units) granted during the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of options outstanding, including both vested and non-vested options. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Number of shares issued under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. View
us-gaap Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) The amount by which the statement of cash flows was affected by a transaction in which equity securities were issued to pay for goods or nonemployee services. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Percentage of vesting of award under share-based payment arrangement. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value of options vested. View
us-gaap Share Price Price of a single share of a number of saleable stocks of a company. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued The fair value of stock issued in noncash financing activities. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) Number of shares issued for noncash consideration for development stage entities. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Shares, Period Increase (Decrease) The increase (decrease) during the period in the number of shares issued. View
us-gaap Stock Issued During Period, Shares, Restricted Stock Award, Gross Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period. View
us-gaap Stock Issued During Period, Value, Acquisitions Value of stock issued pursuant to acquisitions during the period. View
us-gaap Stock Issued During Period, Value, Conversion of Convertible Securities The gross value of stock issued during the period upon the conversion of convertible securities. View
us-gaap Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) Value of shares issued as consideration for cash for development stage entities. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Stock Issued During Period, Value, Other Value of shares of stock issued attributable to transactions classified as other. View
us-gaap Stock Issued During Period, Value, Restricted Stock Award, Gross Aggregate value of stock related to Restricted Stock Awards issued during the period. View
us-gaap Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). View
us-gaap Stock or Unit Option Plan Expense Amount of noncash expense for option under share-based payment arrangement. View
us-gaap Stock Repurchased During Period, Shares Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Stock Repurchased During Period, Value Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock. View
us-gaap Temporary Equity, Par or Stated Value Per Share Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. View
us-gaap Temporary Equity, Shares Outstanding The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. View
us-gaap Transfer to Investments Value of investments transferred to the entity's investments in noncash transactions. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. View
us-gaap Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. View
us-gaap Variable Interest Entity, Consolidated, Carrying Amount, Assets (Deprecated 2020-01-31) The carrying amount of the consolidated Variable Interest Entity's assets included in the reporting entity's statement of financial position. View
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Accounts Payable Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Gain (Loss) Related to Litigation Settlement Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. View
us-gaap Adjustments to Additional Paid in Capital, Warrant Issued Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. View
us-gaap Amortization of Debt Discount (Premium) Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Debt Instrument, Unamortized Discount Amount, after accumulated amortization, of debt discount. View
us-gaap Payments of Debt Issuance Costs The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate The risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Unrecognized Tax Benefits Amount of unrecognized tax benefits. View
us-gaap Warrant, Exercise Price, Increase Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. View
us-gaap APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. View
us-gaap Amortization of Debt Issuance Costs and Discounts Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. View
us-gaap Sale of Stock, Percentage of Ownership after Transaction Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum The maximum risk-free interest rate assumption that is used in valuing an option on its own shares. View
us-gaap Stock Repurchased and Retired During Period, Shares Number of shares that have been repurchased and retired during the period. View
us-gaap Warrants and Rights Outstanding Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. View
us-gaap Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted Net number of non-option equity instruments granted to participants. View
us-gaap Cash, Uninsured Amount The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap 3959134 None View
us-gaap Proceeds from Issuance or Sale of Equity The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. View
Chart of Accounts => Accounts
Name View
Debt Instrument, Convertible, Number of Equity Instruments View
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost View
Increase (Decrease) in Other Current Assets and Liabilities, Net View
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements View
Life Settlement Contract, Investment Method, Premium to be Paid, Year Four View
Net Cash Provided by (Used in) Investing Activities View
Payments to Acquire Businesses, Gross View
Payments to Acquire Furniture and Fixtures View
Payments to Acquire Investments View
Payment to Acquire Life Insurance Policy, Investing Activities View
Payments to Acquire Machinery and Equipment View
Payments to Acquire Notes Receivable View
Preferred Stock, Par or Stated Value Per Share View
Proceeds from Life Insurance Policy View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period View
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum View
Long-term Debt, Gross View
Accounts Payable and Accrued Liabilities, Current View
Accounts Payable and Accrued Liabilities, Noncurrent View
Accounts Payable, Current View
Accrued Liabilities, Current View
Accrued Liabilities View
Additional Paid in Capital View
Additional Paid in Capital, Common Stock View
Adjustments to Additional Paid in Capital, Other View
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition View
APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition View
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs View
Share-based Payment Arrangement, Expense View
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount View
Assets View
Assets, Current View
Assets, Noncurrent View
Business Acquisition, Percentage of Voting Interests Acquired View
Cash Acquired from Acquisition View
Cash and Cash Equivalents, at Carrying Value View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Cash, FDIC Insured Amount View
Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) View
Class of Warrant or Right, Exercise Price of Warrants or Rights View
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right View
Class of Warrant or Right, Number of Securities Called by Warrants or Rights View
Class of Warrant or Right, Outstanding View
Common Stock, Par or Stated Value Per Share View
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Shares Subscribed but Unissued View
Common Stock, Value, Subscriptions View
Common Stock, Value, Issued View
Convertible Debt, Current View
Convertible Debt, Noncurrent View
Cost of Revenue View
Customer Advances, Current View
Debt Conversion, Converted Instrument, Amount View
Debt Conversion, Original Debt, Amount View
Debt Instrument, Face Amount View
Debt Instrument, Interest Rate, Stated Percentage View
Debt Instrument, Periodic Payment View
Deferred Federal Income Tax Expense (Benefit) View
Deferred Income Tax Expense (Benefit) View
Deferred Tax Liabilities, Gross View
Deferred Other Tax Expense (Benefit) View
Deferred State and Local Income Tax Expense (Benefit) View
Deferred Tax Assets, Gross View
Deferred Tax Assets, Net of Valuation Allowance View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Other View
Deferred Tax Assets, Valuation Allowance View
Deferred Tax Liabilities, Net View
Deferred Tax Liabilities, Net, Current View
Deferred Tax Liabilities, Investments View
Deferred Tax Liabilities, Net, Noncurrent View
Depreciation View
Derivative Asset, Notional Amount View
Due to Related Parties, Current View
Due to Related Parties View
Earnings Per Share, Basic View
Earnings Per Share, Basic and Diluted View
Earnings Per Share, Diluted View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent View
Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount View
Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) View
Extinguishment of Debt, Amount View
Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) View
Federal Income Tax Expense (Benefit), Continuing Operations View
Financial Instruments, Owned, at Fair Value View
Financial Instrument Subject to Mandatory Redemption, Maturity, Year One View
Financing Interest Expense View
Gain (Loss) on Sale of Investments View
Gain (Loss) on Disposition of Property Plant Equipment View
Gain (Loss) on Extinguishment of Debt View
General and Administrative Expense View
Gross Profit View
Debt Securities, Held-to-maturity View
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain View
Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss View
Debt Securities, Held-to-maturity, Fair Value View
Other than Temporary Impairment Losses, Investments View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest View
Income Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount View
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount View
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount View
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount View
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount View
Increase (Decrease) in Accounts Payable View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Accounts Payable, Related Parties View
Increase (Decrease) in Income Taxes Payable View
Increase (Decrease) in Accrued Interest Receivable, Net View
Increase (Decrease) in Accrued Liabilities View
Increase (Decrease) in Interest Payable, Net View
Increase (Decrease) in Other Current Assets View
Increase (Decrease) in Other Noncurrent Assets View
Increase (Decrease) in Other Operating Assets View
Increase (Decrease) in Prepaid Expense and Other Assets View
Increase (Decrease) in Prepaid Expense View
Interest Expense View
Interest Income, Operating View
Interest Income, Other View
Interest Paid, Including Capitalized Interest, Operating and Investing Activities View
Interest Paid, Excluding Capitalized Interest, Operating Activities View
Interest Payable, Current View
Interest Payable View
Interest Receivable View
Investment Income, Interest View
Issuance of Stock and Warrants for Services or Claims View
Operating Leases, Rent Expense View
Liabilities View
Liabilities and Equity View
Liabilities Assumed View
Liabilities, Current View
Liabilities, Noncurrent View
Liability for Future Policy Benefit, before Reinsurance View
Liability for Future Policy Benefits, Life View
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment View
Life Settlement Contracts, Fair Value Method, Face Value View
Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Five View
Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Four View
Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Three View
Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Two View
Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Five View
Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Four View
Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Three View
Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Two View
Life Settlement Contracts, Fair Value Method, Number of Contracts View
Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Five View
Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Four View
Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Three View
Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Two View
Life Settlement Contracts, Investment Method, Carrying Amount View
Life Settlement Contracts, Investment Method, Face Value View
Life Settlement Contract, Investment Method, Face Value, Maturity, after Year Five View
Life Settlement Contract, Investment Method, Face Value, Maturity, Year One View
Life Settlement Contract, Investment Method, Face Value, Maturity, Year Five View
Life Settlement Contract, Investment Method, Face Value, Maturity, Year Four View
Life Settlement Contract, Investment Method, Face Value, Maturity, Year Three View
Life Settlement Contract, Investment Method, Face Value, Maturity, Year Two View
Life Settlement Contracts, Investment Method, Premiums to be Paid View
Life Settlement Contracts, Investment Method, Number of Contracts View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, after Year Five View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year One View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Five View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Four View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Three View
Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Two View
Life Settlement Contract, Investment Method, Premium to be Paid, after Year Five View
Life Settlement Contract, Investment Method, Premium to be Paid, Year One View
Life Settlement Contract, Investment Method, Premium to be Paid, Year Five View
Life Settlement Contract, Investment Method, Premium to be Paid, Year Three View
Life Settlement Contract, Investment Method, Premium to be Paid, Year Two View
Long-term Line of Credit View
Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) View
Line of Credit Facility, Maximum Borrowing Capacity View
Line of Credit Facility, Remaining Borrowing Capacity View
Loan Processing Fee View
Long-Term Debt, Maturity, Year One View
Notes Payable, Noncurrent View
Loss Contingency, Damages Sought, Value View
Net Cash Provided by (Used in) Financing Activities View
Net Cash Provided by (Used in) Financing Activities, Continuing Operations View
Net Cash Provided by (Used in) Investing Activities, Continuing Operations View
Net Cash Provided by (Used in) Operating Activities View
Net Cash Provided by (Used in) Operating Activities, Continuing Operations View
Net Income (Loss) Attributable to Parent View
Nonoperating Income (Expense) View
Financing Receivable, before Allowance for Credit Loss, Current View
Notes Payable View
Notes Payable, Current View
Notes Payable, Related Parties, Current View
Notes Payable, Related Parties View
Notes Payable, Related Parties, Noncurrent View
Financing Receivable, after Allowance for Credit Loss View
Notes Reduction View
Operating Expenses View
Operating Income (Loss) View
Operating Leases, Rent Expense, Net View
Operating Loss Carryforwards View
Other Accrued Liabilities, Current View
Other Assets, Current View
Other Assets, Miscellaneous, Noncurrent View
Other Assets, Noncurrent View
Other Commitment View
Other Liabilities, Current View
Other Long-term Debt View
Other Nonoperating Income View
Other Nonoperating Income (Expense) View
Other Notes Payable View
Other Restricted Assets, Noncurrent View
Other Significant Noncash Transaction, Value of Consideration Given View
Payments for Advance to Affiliate View
Payments for (Proceeds from) Loans Receivable View
Payments for Repurchase of Common Stock View
Payments of Loan Costs View
Payments of Stock Issuance Costs View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Shares Outstanding View
Premiums Receivable, Net View
Prepaid Expense and Other Assets View
Prepaid Expense and Other Assets, Current View
Prepaid Expense, Current View
Proceeds from Collection of Loans Receivable View
Proceeds from Collection of Long-term Loans to Related Parties View
Proceeds from Convertible Debt View
Proceeds from Issuance of Common Stock View
Proceeds from Issuance of Debt View
Proceeds from Issuance of Private Placement View
Proceeds from Issuance of Warrants View
Proceeds from Notes Payable View
Proceeds from Other Debt View
Proceeds from Other Equity View
Proceeds from (Payments for) Other Financing Activities View
Proceeds from Related Party Debt View
Proceeds from (Repayments of) Related Party Debt View
Proceeds from Sale and Maturity of Other Investments View
Proceeds from Sale of Machinery and Equipment View
Proceeds from Stock Options Exercised View
Professional Fees View
Receivable from Shareholders or Affiliates for Issuance of Capital Stock View
Related Party Transaction, Amounts of Transaction View
Related Party Transaction, Rate View
Repayments of Convertible Debt View
Repayments of Notes Payable View
Repayments of Related Party Debt View
Restructuring and Related Cost, Incurred Cost View
Retained Earnings (Accumulated Deficit) View
Revenues View
Selling and Marketing Expense View
Share-based Payment Arrangement, Noncash Expense View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price View
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period View
Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) View
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value View
Share Price View
Stockholders' Equity Attributable to Parent View
Stock Issued View
Stock Issued During Period, Shares, Acquisitions View
Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) View
Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Shares, Period Increase (Decrease) View
Stock Issued During Period, Shares, Restricted Stock Award, Gross View
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period View
Stock Issued During Period, Value, Acquisitions View
Stock Issued During Period, Value, Conversion of Convertible Securities View
Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Stock Issued During Period, Value, Other View
Stock Issued During Period, Value, Restricted Stock Award, Gross View
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture View
Stock or Unit Option Plan Expense View
Stock Repurchased During Period, Shares View
Stock Repurchased During Period, Value View
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests View
Temporary Equity, Par or Stated Value Per Share View
Temporary Equity, Redemption Price Per Share View
Temporary Equity, Shares Issued View
Temporary Equity, Shares Outstanding View
Transfer to Investments View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued View
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense View
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount View
Variable Interest Entity, Consolidated, Carrying Amount, Assets (Deprecated 2020-01-31) View
Weighted Average Number Diluted Shares Outstanding Adjustment View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Accounts Payable View
Gain (Loss) Related to Litigation Settlement View
Adjustments to Additional Paid in Capital, Warrant Issued View
Amortization of Debt Discount (Premium) View
Cash View
Debt Instrument, Unamortized Discount View
Payments of Debt Issuance Costs View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate View
Unrecognized Tax Benefits View
Warrant, Exercise Price, Increase View
APIC, Share-based Payment Arrangement, Increase for Cost Recognition View
Amortization of Debt Issuance Costs and Discounts View
Sale of Stock, Percentage of Ownership after Transaction View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum View
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum View
Stock Repurchased and Retired During Period, Shares View
Warrants and Rights Outstanding View
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted View
Cash, Uninsured Amount View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
3924724 View
Proceeds from Issuance or Sale of Equity View
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations View